These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9585908)

  • 41. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Rubiales AS; del Valle ML
    Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
    [No Abstract]   [Full Text] [Related]  

  • 42. [Patient preference for oral chemotherapy].
    Schöffski P
    Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
    [No Abstract]   [Full Text] [Related]  

  • 43. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
    Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
    Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Capsule instead of infusion--new oral chemotherapy option].
    Köhne CH
    Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
    Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
    Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Side effects analyses in consideration of renal function for S-1-administered patients].
    Iwai M; Kimura M; Yoshimura T; Yasuda T
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):973-6. PubMed ID: 21677489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pulmonary veno-occlusive disease developed in a man given long-term treatment with anticancerous agents].
    Maemondo M; Ebina A; Saitou K
    Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):823-8. PubMed ID: 9866989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tegafur--preoperative treatment with tegafur suppositories for rectal cancer].
    Ohwada S; Sato Y; Yoshimura S; Kawate S; Morishita Y; Kashiwabara K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():341-4. PubMed ID: 14574908
    [No Abstract]   [Full Text] [Related]  

  • 50. [Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report].
    Araki M; Nakazuru S; Itoh M; Suemura S; Mitsuta C; Sueyoshi Y; Ota M; Ohta T; Hasegawa H; Tatsumi K; Yoshio T; Toyama T; Kuzushita N; Mita E
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1857-9. PubMed ID: 22083197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors of pathologic stage IB non-small cell lung cancer.
    Yano M; Sasaki H; Moriyama S; Kawano O; Hikosaka Y; Fujii Y
    Ann Thorac Cardiovasc Surg; 2011; 17(1):58-62. PubMed ID: 21587131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy].
    Matsuyama S; Takei M; Kido S; Magata S; Motoyama K; Kitahara K; Miyazaki K
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):547-9. PubMed ID: 12722690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sorafenib-induced palmoplantar hyperkeratosis.
    Lountzis NI; Maroon MS
    J Drugs Dermatol; 2008 Jun; 7(6):588-9. PubMed ID: 18561593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
    Amano A; Ohkawa S; Ueno M
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1307-9. PubMed ID: 17687220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
    Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
    Furuse J; Nakachi K; Suzuki E; Shimizu S; Ishii H; Yoshino M
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1679-82. PubMed ID: 17940390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
    Ikeda M; Ueno H
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1515-9. PubMed ID: 17033250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
    Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
    Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous manifestations of occupational chronic arsenical poisoning. (Studies on lead arsenate poisoning, Part 3).
    Hamada T; Horiguchi S; Nakano H
    Osaka City Med J; 1977; 23(1):9-20. PubMed ID: 147434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.